327 related articles for article (PubMed ID: 19826409)
1. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
3. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
6. Validation of self-reported history of colorectal cancer screening.
Khoja S; McGregor SE; Hilsden RJ
Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
[TBL] [Abstract][Full Text] [Related]
7. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.
Farmer MM; Bastani R; Kwan L; Belman M; Ganz PA
Cancer; 2008 Mar; 112(6):1230-8. PubMed ID: 18266204
[TBL] [Abstract][Full Text] [Related]
8. Predictors of colorectal cancer screening participation in the United States.
Ioannou GN; Chapko MK; Dominitz JA
Am J Gastroenterol; 2003 Sep; 98(9):2082-91. PubMed ID: 14499792
[TBL] [Abstract][Full Text] [Related]
9. Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting.
Senore C; Ederle A; Fantin A; Andreoni B; Bisanti L; Grazzini G; Zappa M; Ferrero F; Marutti A; Giuliani O; Armaroli P; Segnan N
J Med Screen; 2011; 18(3):128-34. PubMed ID: 22045821
[TBL] [Abstract][Full Text] [Related]
10. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer.
Eloubeidi MA; Wallace MB; Desmond R; Farraye FA
Am J Gastroenterol; 2003 Jul; 98(7):1634-9. PubMed ID: 12873591
[TBL] [Abstract][Full Text] [Related]
11. Trends in colorectal cancer testing among Medicare subpopulations.
Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening among Mexican Americans at a community clinic.
Yepes-Rios M; Reimann JO; Talavera AC; Ruiz de Esparza A; Talavera GA
Am J Prev Med; 2006 Mar; 30(3):204-10. PubMed ID: 16476635
[TBL] [Abstract][Full Text] [Related]
13. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
[TBL] [Abstract][Full Text] [Related]
14. Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting.
Dulai GS; Farmer MM; Ganz PA; Bernaards CA; Qi K; Dietrich AJ; Bastani R; Belman MJ; Kahn KL
Cancer; 2004 May; 100(9):1843-52. PubMed ID: 15112264
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
16. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
17. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
19. Offering people a choice for colorectal cancer screening.
Senore C; Ederle A; Benazzato L; Arrigoni A; Silvani M; Fantin A; Fracchia M; Armaroli P; Segnan N
Gut; 2013 May; 62(5):735-40. PubMed ID: 22442162
[TBL] [Abstract][Full Text] [Related]
20. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
